Re: Assessing Cancer Progression and Stable Disease after Neoadjuvant Chemotherapy for Organ-Confined Muscle-Invasive Bladder Cancer Editorial Comment

被引:0
|
作者
Chang, Sam S.
机构
来源
JOURNAL OF UROLOGY | 2019年 / 201卷 / 03期
关键词
D O I
暂无
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:441 / 441
页数:1
相关论文
共 50 条
  • [21] Multicenter Assessment of Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer
    Zargar, Homayoun
    Espiritu, Patrick N.
    Fairey, Adrian S.
    Mertens, Laura S.
    Dinney, Colin P.
    Mir, Maria C.
    Krabbe, Laura-Maria
    Cookson, Michael S.
    Jacobsen, Niels-Erik
    Gandhi, Nilay M.
    Griffin, Joshua
    Montgomery, Jeffrey S.
    Vasdev, Nikhil
    Yu, Evan Y.
    Youssef, David
    Xylinas, Evanguelos
    Campain, Nicholas J.
    Kassouf, Wassim
    Dall'Era, Marc A.
    Seah, Jo-An
    Ercole, Cesar E.
    Horenblas, Simon
    Sridhar, Srikala S.
    McGrath, John S.
    Aning, Jonathan
    Shariat, Shahrokh F.
    Wright, Jonathan L.
    Thorpe, Andrew C.
    Morgan, Todd M.
    Holzbeierlein, Jeff M.
    Bivalacqua, Trinity J.
    North, Scott
    Barocas, Daniel A.
    Lotan, Yair
    Garcia, Jorge A.
    Stephenson, Andrew J.
    Shah, Jay B.
    van Rhijn, Bas W.
    Daneshmand, Siamak
    Spiess, Philippe E.
    Black, Peter C.
    EUROPEAN UROLOGY, 2015, 67 (02) : 241 - 249
  • [22] Comparison of Neoadjuvant and Adjuvant Chemotherapy in Muscle-invasive Bladder Cancer
    Macleod, Liam C.
    Fam, Mina M.
    Yabes, Jonathan G.
    Hale, Nathan E.
    Turner, Robert M., II
    Lopa, Samia H.
    Gingrich, Jeffrey R.
    Borza, Tudor
    Skolarus, Ted A.
    Davies, Benjamin J.
    Jacobs, Bruce L.
    CLINICAL GENITOURINARY CANCER, 2020, 18 (03) : 201 - +
  • [23] Multicenter Assessment of Neoadjuvant Chemotherapy for Muscle-Invasive Bladder Cancer
    Vasdev, N.
    Zargar, H.
    Fairey, A.
    Espiritu, P.
    Krabbe, L.
    Mongomery, J.
    Gandhi, N.
    Griffin, J.
    Yu, E.
    Campain, N.
    Xylinas, E.
    Horenblas, S.
    Yousef, D.
    Kassouf, W.
    Shariat, S.
    Aning, J.
    Wright, J.
    Holzbeierlein, J.
    Bivalacqua, T.
    Morgan, T.
    North, S.
    Borcas, D.
    Lotan, Y.
    Shah, J.
    Spiess, P.
    Van Rhijn, B.
    Daneshmand, S.
    Black, P.
    Thorpe, A. C.
    BJU INTERNATIONAL, 2014, 113 : 25 - 25
  • [24] Neoadjuvant versus adjuvant chemotherapy for muscle-invasive bladder cancer
    Clark, Peter E.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (06) : 821 - 830
  • [25] Re: Chemoradiotherapy in Octogenarians as Primary Treatment for Muscle-Invasive Bladder Cancer Editorial Comment
    Griebling, Tomas L.
    JOURNAL OF UROLOGY, 2018, 199 (03): : 592 - 593
  • [26] A phase Ⅱ study of neoadjuvant chemotherapy followed by organ preservation in patients with muscle-invasive bladder cancer
    Chinna Babu Dracham
    Narendra Kumar
    Santosh Kumar
    Arun Elangovan
    Budhi Singh Yadav
    Ravimohan SMavuduru
    Anupam Lal
    Pramod KGupta
    Rakesh Kapoor
    Asian Journal of Urology, 2022, (03) : 318 - 328
  • [27] Re: Radiotherapy with or without Chemotherapy in Muscle-invasive Bladder Cancer
    Efstathiou, Jason A.
    Shipley, William U.
    EUROPEAN UROLOGY, 2013, 63 (01) : 181 - 182
  • [28] The Role of Neoadjuvant Chemotherapy in Bladder Preservation Approaches in Muscle-Invasive Bladder Cancer
    Stecca, Carlos
    Mitin, Timur
    Sridhar, Srikala S.
    SEMINARS IN RADIATION ONCOLOGY, 2023, 33 (01) : 51 - 55
  • [29] Efficient delivery of radical cystectomy after neoadjuvant chemotherapy for muscle-invasive bladder cancer
    Alva, Ajjai S.
    Tallman, Christopher T.
    He, Chang
    Hussain, Maha H.
    Hafez, Khaled
    Montie, James E.
    Smith, David C.
    Weizer, Alon Z.
    Wood, David
    Lee, Cheryl T.
    CANCER, 2012, 118 (01) : 44 - 53
  • [30] Chemotherapy for Muscle-Invasive Bladder Cancer
    Patrizia Trenta
    Fabio Calabrò
    Linda Cerbone
    Cora N. Sternberg
    Current Treatment Options in Oncology, 2016, 17